Fundraising Fox
/Companies
Sign in

Appello Pharmaceuticals

Nashville, US · Founded 2017 · Delaware corporation · 3 known investors

Find your way into Appello Pharmaceuticals

Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases. The company leverages scientific expertise and infrastructure to advance novel therapeutics through preclinical and clinical development.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

Appello Pharmaceuticals was founded in 2017 by Dr. Laden.

DL
Dr. LadenCo-founder
CR
Christopher RandNamed on SEC filing
VB
Vaughn BrysonNamed on SEC filing
JP
Jeff P. ConnNamed on SEC filing

Board

WS
William SlatteryBoard director
HFHowie Furst
Howie FurstBoard directorPartner at Deerfield Management Company
JC
Joseph Cook, Jr.Board director

Investors · 3

Relevance Ventureslisted by Relevance VenturesBrentwood · $250K – $2.5M

How we know: Relevance Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Deerfield Management CompanyinferredNew Yorkvia Howard Furst · board

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$29M disclosed across 2 rounds · 2018–2022

▶$13.5MraisedJan 2022 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Vaughn BrysonDirector
  • Howard FurstDirector
  • Christopher RandExecutive Officer
  • Joseph Cook, Jr.Director
  • Brian LadenExecutive Officer, Director
  • William SlatteryDirector
  • Jeff P. ConnDirector
Offering amount
$13.5M
Amount sold
$13.5M
Minimum investment
$1
First sale
Jan 2022
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.5MraisedNov 2020 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher RandExecutive Officer
  • William SlatteryDirector
  • Brian LadenExecutive Officer, Director
  • Howie FurstDirector
  • Vaughn BrysonDirector
  • Joseph Cook, Jr.Director
  • Jeff P. ConnDirector
Offering amount
$15.6M
Amount sold
$15.5M
Minimum investment
$1
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Eli Lilly9 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

Companies competing with Appello Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Appello Pharmaceuticals do?
Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases. The company leverages scientific expertise and infrastructure to advance novel therapeutics through preclinical and clinical development.
Who founded Appello Pharmaceuticals?
Appello Pharmaceuticals was founded by Dr. Laden in 2017.
Who are Appello Pharmaceuticals's investors?
Appello Pharmaceuticals's investors include Mountain Group Capital, Relevance Ventures, Deerfield Management Company.
How much funding has Appello Pharmaceuticals raised?
Appello Pharmaceuticals has disclosed $29M raised across 2 rounds.
Where is Appello Pharmaceuticals headquartered?
Appello Pharmaceuticals is headquartered in Nashville, US.